Showing results (11-20 of 148) with videos related to

Sort By:
Pageof 15
Current Cardiology Reviews|May 3, 2011
The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular DiseaseLatika Sibal, Sharad C Agarwal, Philip D Home, et al.
Pharmacoepidemiology and Drug Safety|January 25, 2012
Macrovascular and microvascular outcomes after beginning of insulin versus additional oral glucose-lowering therapy in people with type 2 diabetes: an observational studyGillian C Hall, Alex D McMahon, Dawn Carroll, et al.
Diabetes Care|May 15, 2014
Factors associated with weight gain in people with type 2 diabetes starting on insulinBeverley Balkau, Philip D Home, Maya Vincent, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 12, 2018
Cost-Effectiveness of Insulin Degludec vs. Insulin Glargine U100 in Type 1 and Type 2 Diabetes Mellitus in a UK SettingMarc Evans, Roopa Mehta, Jens Gundgaard, et al.
Annals of Medicine|June 24, 2021
Practical guidance on the initiation, titration, and switching of basal insulins: a narrative review for primary careRoopa Mehta, Ronald Goldenberg, Daniel Katselnik, et al.
Diabetes Care|March 15, 2008
Treatment satisfaction and quality of life with insulin glargine plus insulin lispro compared with NPH insulin plus unmodified human insulin in individuals with type 1 diabetesSimon G Ashwell, Clare Bradley, James W Stephens, et al.
Diabetes Research and Clinical Practice|October 15, 2013
The effectiveness and safety of beginning insulin aspart together with basal insulin in people with type 2 diabetes in non-Western nations: results from the A₁chieve observational studyPhilip D Home, Zafar A Latif, Guillermo González-Gálvez, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 16, 2022
Transitioning from basal-bolus or premix insulin therapy to a combination of basal insulin and glucagon-like peptide-1 receptor agonist in people with type 2 diabetesRoopa Mehta, Liana K Billings, Andreas Liebl, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 31, 2014
Safety, tolerability, and efficacy of insulin aspart in people with type 2 diabetes, as biphasic insulin aspart or with Basal insulin: findings from the multinational, non-interventional a1chieve studyIssam Hajjaji, Siddharth Shah, Yuxiu Li, et al.
Diabetes, Obesity & Metabolism|April 22, 2020
Hypoglycaemia risk with insulin glargine 300 U/mL compared with glargine 100 U/mL across different baseline fasting C-peptide levels in insulin-naïve people with type 2 diabetes: A post hoc analysis of the EDITION 3 trialGeremia B Bolli, Wolfgang Landgraf, Zsolt Bosnyak, et al.
Pageof 15